Ece Özdemir Öktem
Research Subjects
Research Interests
Ece Özdemir Öktem has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Burak Yulug
Department of Neurology, Alanya Alaaddin Keykubat University, Türkiye
9 shared publications - Ahmet Özşimşek
Department of Neurology, Alanya Alaaddin Keykubat Üniversitesi, 07400 Alanya, Türkiye
8 shared publications - Şeyda Çankaya
Alanya Alaaddin Keykubat Üniversitesi
8 shared publications - Dila Sayman3 shared publications
- Ceyhun Sayman
Haydarpasa Numune Training & Res Hosp, Dept Norol, Istanbul, Turkey
2 shared publications - Fatih Aslan
Alaattin Keykubat University, Department of Ophthalmology, Alanya, Antalya, Turkey
2 shared publications
Latest Publications
- Open Access
- 29 October 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (4) , 68-72
The impact of high dose corticosteroid treatment affect on cardiac abnormalities in patients with multiple sclerosis
Aims: High-dose corticosteroids to control acute relapses of multiple sclerosis, leveraging their anti-inflammatory effects. However, these treatments can lead to cardiovascular side effects. Understanding the pathophysiology of corticosteroid induced bradycardia is paramount for healthcare providers. Our aim in this study are to identify risk factors for cardiac side effects and assess the timing of cardiac complications relative to treatment. Methods: Patients who met the McDonald's criteria for definite MS and patients requiring admission for pulse steroid treatment with an acute recurrence were included.Individuals taking cardiac medications, or with a heart illness were excluded.Patients were given 1 g IV methylprednisolone in 2 hours for five to seven days in order to treat acute relapses. Results: We studied with 23 patients(6 males and 17 females, 26.1/73.9% respectively).The mean±SD age of the patients was 34.6±9.9 (18-43) years and the mean±SD duration of disease was 5.5±4.9 years.Most of the patients were relapsing–remitting MS in 73.9%, primary progressive in 4.4% and secondary progressive in 21.7%.The most common cardiac arhythmia during corticosteroid pulse therapy was sinus bradycradia(n=6). Conclusion: The combination of direct effects on cardiac myocytes, electrolyte disturbances, autonomic dysfunction, and individual genetic factors can contribute to the development of bradycardia in MS patients treated with high-dose methylprednisolone. Close monitoring and prompt intervention are crucial to manage this adverse effect and optimize patient safety.
- 29 October 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (4) , 68-72
Open AccessThe impact of high dose corticosteroid treatment affect on cardiac abnormalities in patients with multiple sclerosis
Aims: High-dose corticosteroids to control acute relapses of multiple sclerosis, leveraging their anti-inflammatory effects. However, these treatments can lead to cardiovascular side effects. Understanding the pathophysiology of corticosteroid induced bradycardia is paramount for healthcare providers. Our aim in this study are to identify risk factors for cardiac side effects and assess the timing of cardiac complications relative to treatment. Methods: Patients who met the McDonald's criteria for definite MS and patients requiring admission for pulse steroid treatment with an acute recurrence were included.Individuals taking cardiac medications, or with a heart illness were excluded.Patients were given 1 g IV methylprednisolone in 2 hours for five to seven days in order to treat acute relapses. Results: We studied with 23 patients(6 males and 17 females, 26.1/73.9% respectively).The mean±SD age of the patients was 34.6±9.9 (18-43) years and the mean±SD duration of disease was 5.5±4.9 years.Most of the patients were relapsing–remitting MS in 73.9%, primary progressive in 4.4% and secondary progressive in 21.7%.The most common cardiac arhythmia during corticosteroid pulse therapy was sinus bradycradia(n=6). Conclusion: The combination of direct effects on cardiac myocytes, electrolyte disturbances, autonomic dysfunction, and individual genetic factors can contribute to the development of bradycardia in MS patients treated with high-dose methylprednisolone. Close monitoring and prompt intervention are crucial to manage this adverse effect and optimize patient safety.
- Open Access
- 29 October 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (4) , 78-80
Third cranial nerve palsy with confirmed HHV-6 positivity
We present a rare case of a 38-year-old man diagnosed with third cranial nerve paralysis, where no abnormalities were detected on MRI. Human Herpes Virus-6 (HHV-6) infection affecting the central nervous system and associated with cranial nerve paralysis is an unusual occurrence. This report underscores the importance of considering HHV-6 as a differential diagnosis in patients presenting with cranial nerve palsy and suggests the use of cerebrospinal fluid (CSF) HHV-6 polymerase chain reaction (PCR) testing for confirmation.
- 29 October 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (4) , 78-80
Open AccessThird cranial nerve palsy with confirmed HHV-6 positivity
We present a rare case of a 38-year-old man diagnosed with third cranial nerve paralysis, where no abnormalities were detected on MRI. Human Herpes Virus-6 (HHV-6) infection affecting the central nervous system and associated with cranial nerve paralysis is an unusual occurrence. This report underscores the importance of considering HHV-6 as a differential diagnosis in patients presenting with cranial nerve palsy and suggests the use of cerebrospinal fluid (CSF) HHV-6 polymerase chain reaction (PCR) testing for confirmation.
- Open Access
- 1 September 2024
- Published by Turk Noroloji Dernegi in Turkish Journal Of Neurology
- Vol. 30 (3) , 198-200
Cavernous sinus thrombosis due to mucor infection of ethmoid sinus
- 1 September 2024
- Published by Turk Noroloji Dernegi in Turkish Journal Of Neurology
- Vol. 30 (3) , 198-200
Open AccessCavernous sinus thrombosis due to mucor infection of ethmoid sinus
- Open Access
- 30 April 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (2) , 33-35
A rare case of hereditary ataxia: Gordon Holmes syndrome: a review of the literature
Gordon Holmes syndrome is an extremely rare, autosomal recessive condition with characteristic features of cerebellar progressive ataxia, cerebellar atrophy, and hypogonadotropic hypogonadism, which was first described in 1908 by the British neurologist of the same name. Two genes have to date been frequently associated with this syndrome, RNF216 and PNPLA61. A 23-year-old man presented with secondary sexual character deficiency and progressive difficulty in gait persisting for several years. He was eventually immobilized after seven years of ongoing symptoms and was definitively diagnosed with Gordon Holmes syndrome after genetic testing revealed RNF216 gene mutation.
- 30 April 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (2) , 33-35
Open AccessA rare case of hereditary ataxia: Gordon Holmes syndrome: a review of the literature
Gordon Holmes syndrome is an extremely rare, autosomal recessive condition with characteristic features of cerebellar progressive ataxia, cerebellar atrophy, and hypogonadotropic hypogonadism, which was first described in 1908 by the British neurologist of the same name. Two genes have to date been frequently associated with this syndrome, RNF216 and PNPLA61. A 23-year-old man presented with secondary sexual character deficiency and progressive difficulty in gait persisting for several years. He was eventually immobilized after seven years of ongoing symptoms and was definitively diagnosed with Gordon Holmes syndrome after genetic testing revealed RNF216 gene mutation.
- Open Access
- 31 January 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (1) , 14-16
Hemorrhage in sinus vein thrombosis: the "cashew sign"
Intracerebral hemorrhages are quite common in sinus vein thrombosis (SVT). The morphology of these hemorrhages may vary from small localized juxtacortical lesions and subarachnoid hemorrhages to large hemorrhagic infarcts (Coutinho, van den Berg et al. 2014). In this presentation, we aimed to emphasize venous hemorrhage and the "cashew sign" seen in SVT.
- 31 January 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (1) , 14-16
Open AccessHemorrhage in sinus vein thrombosis: the "cashew sign"
Intracerebral hemorrhages are quite common in sinus vein thrombosis (SVT). The morphology of these hemorrhages may vary from small localized juxtacortical lesions and subarachnoid hemorrhages to large hemorrhagic infarcts (Coutinho, van den Berg et al. 2014). In this presentation, we aimed to emphasize venous hemorrhage and the "cashew sign" seen in SVT.
- Open Access
- 31 January 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (1) , 17-19
Isolated eight-and-a-half syndrome associated with pontin hemorrhage: a rare clinical presentation with topological significance
The eight-and-a-half syndrome is a critical clinical condition defined by peripheral facial palsy and the ocular symptoms mostly linked to ischemic cerebrovascular disease affecting the pontin tegmentum. We present a case of isolated eight-and-a-half syndrome with a pontine hemorrhage and discuss it’s topological implications in context of neurological practice. This is the one of few cases presenting with eight-and-a-half syndrome following the pontine hemorrhage. Despite showing similar clinical features and clinical prognosis the our case is intriguing due to its unique topological anatomy demonstrating an initial improvement in ocular symptoms.
- 31 January 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (1) , 17-19
Open AccessIsolated eight-and-a-half syndrome associated with pontin hemorrhage: a rare clinical presentation with topological significance
The eight-and-a-half syndrome is a critical clinical condition defined by peripheral facial palsy and the ocular symptoms mostly linked to ischemic cerebrovascular disease affecting the pontin tegmentum. We present a case of isolated eight-and-a-half syndrome with a pontine hemorrhage and discuss it’s topological implications in context of neurological practice. This is the one of few cases presenting with eight-and-a-half syndrome following the pontine hemorrhage. Despite showing similar clinical features and clinical prognosis the our case is intriguing due to its unique topological anatomy demonstrating an initial improvement in ocular symptoms.
- 30 April 2023
- Published by Care Comm in Česká a slovenská neurologie a neurochirurgie
- Vol. 86/119 (3) , 121-127
Cerebral volume alterations in late-onset monocular blindness – a volumetric imaging study
- 30 April 2023
- Published by Care Comm in Česká a slovenská neurologie a neurochirurgie
- Vol. 86/119 (3) , 121-127
Cerebral volume alterations in late-onset monocular blindness – a volumetric imaging study
- 4 February 2023
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 46 (4) , 334-340
The role of temperament in evaluating the relationship between symptoms and signs in dry eye disease
- 4 February 2023
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 46 (4) , 334-340
The role of temperament in evaluating the relationship between symptoms and signs in dry eye disease
- Open Access
- 31 December 2022
- Published by Acta Medica Alanya in Acta Medica Alanya
- Vol. 6 (3) , 301-306
Different metabolic and clinical profiles between patients with pure Alzheimer dementia and epileptic Alzheimer dementia: a metabolic study
Aim: To investigate the clinical characteristics and cerebral FDG PET metabolisms of dementia patients who were also diagnosed with epilepsy and compare the differences with pure Alzheimer dementia patients.Methods: In this case-control study, a total of 14 patients, 7 patients with pure Alzheimer disease as a control group and 7 age and gender-matched patients with Alzheimer disease and concomitant epilepsy as a study group, were included. Detailed neurocognitive battery and brain fludeoxyglucose positron emission tomography (FDG PET-CT) were performed for all subjects.Results: In comparison of neurocognitive test scores, there was no significant difference between the study and control groups. However, geriatric depression scale scores were significantly lower in study group than the controls (p= 0.026). In cerebral FDG-PET CT profiles of subjects we detected significantly lower metabolism in left and right cerebellum, left lentiform nucleus, right thalamus and vermis in the study group (p=0.008, p=0.023, p=0.003, p=0.002, p=0.002, respectively). In the right parietotemporal cortex and right and left associative visual cortex, we found higher metabolism in the study group than controls (p=0.023, p=0.012, p=0.003, respectively).Conclusion: Epileptic patients with Alzheimer’s dementia may have distinct clinical and metabolic profiles, than pure Alzheimer’s disease patients. Even if there is no difference in the neurocognitive clinical scores of the patients, depression and related functional abnormalities may be a biomarker of epileptic AD.
- 31 December 2022
- Published by Acta Medica Alanya in Acta Medica Alanya
- Vol. 6 (3) , 301-306
Open AccessDifferent metabolic and clinical profiles between patients with pure Alzheimer dementia and epileptic Alzheimer dementia: a metabolic study
Aim: To investigate the clinical characteristics and cerebral FDG PET metabolisms of dementia patients who were also diagnosed with epilepsy and compare the differences with pure Alzheimer dementia patients.Methods: In this case-control study, a total of 14 patients, 7 patients with pure Alzheimer disease as a control group and 7 age and gender-matched patients with Alzheimer disease and concomitant epilepsy as a study group, were included. Detailed neurocognitive battery and brain fludeoxyglucose positron emission tomography (FDG PET-CT) were performed for all subjects.Results: In comparison of neurocognitive test scores, there was no significant difference between the study and control groups. However, geriatric depression scale scores were significantly lower in study group than the controls (p= 0.026). In cerebral FDG-PET CT profiles of subjects we detected significantly lower metabolism in left and right cerebellum, left lentiform nucleus, right thalamus and vermis in the study group (p=0.008, p=0.023, p=0.003, p=0.002, p=0.002, respectively). In the right parietotemporal cortex and right and left associative visual cortex, we found higher metabolism in the study group than controls (p=0.023, p=0.012, p=0.003, respectively).Conclusion: Epileptic patients with Alzheimer’s dementia may have distinct clinical and metabolic profiles, than pure Alzheimer’s disease patients. Even if there is no difference in the neurocognitive clinical scores of the patients, depression and related functional abnormalities may be a biomarker of epileptic AD.